U.MIR PHARMA LTDActive
Key figures
Like most small UK companies, U.MIR PHARMA LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 271,343 | 111,649 | 7,546 | 71,135 | 28,751 |
| Total assets | 593,217 | 564,334 | 537,903 | 686,346 | 552,886 |
| Total liabilities | 533,836 | 481,528 | 433,633 | 519,306 | 430,007 |
| Net assets / total equity | 61,381 | 84,806 | 104,270 | 167,040 | 122,879 |
| Average number of employees | 12 | 13 | 13 | 18 | 21 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: U.MIR PHARMA LTD
Company
U.MIR PHARMA LTD is a private limited company registered with Companies House under company number 07321929. It was incorporated on 21 Jul 2010. Its status is active. The registered office is in Newcastle (ST5). Its nature of business (SIC 2007) is other human health activities (86900).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files abridged accounts (unaudited). Net assets were £122,879, down 26.4% on the previous year. Cash at bank and in hand was £28,751. Total assets were £552,886 and total liabilities £430,007. The company had an average of 21 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 11 Apr 2027.